Spin-out Venture of University of Maryland Secures Exclusive License to Develops Digital Therapeutic Platform for Neuromodulation of Pain Sensitivity

Spin out Venture of University of Maryland Secures Exclusive License to Develops Digital Therapeutic Platform for Neuromodulation of Pain Sensitivity

A University of Maryland graduate student and team of advisors developed a technology involving the analysis of brain waves using EEG to assess a particular individual's sensitivity to pain. Andrew Furman—that graduate student—went on to form Empower Therapeutics Inc. (Empower) in Baltimore, Maryland, to secure the rights to the intellectual property to develop a cutting-edge digital therapeutics platform used to ascertain and modulate sensitivity for chronic pain. Furman's advisors include Dave Seminowicz, Ph.D., of UMB, and Ali Mazaheri, Ph.D., of the University of Birmingham—both the University of Maryland and the University of Birmingham owned the original rights. With licensure in hand, Empower pursues the development of a biomarker for pain sensitivity enabling the targeting of therapies to reverse the underlying changes in the central nervous system.

Background Research

Over the past five years, Dr. Seminowicz's lab discovered and validated a simple, portable, and non-invasive method for determining an individual's pain sensitivity using EEG. The initial proof-of-concept was established in a capsaicin-induced thermal pain study. Researchers then validated the approach...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee